Cover Image
市場調查報告書

人工心臟設備的全球市場:2015∼2019年

Global Cardiac Prosthetic Devices Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 332629
出版日期 內容資訊 英文 96 Pages
訂單完成後即時交付
價格
Back to Top
人工心臟設備的全球市場:2015∼2019年 Global Cardiac Prosthetic Devices Market 2015-2019
出版日期: 2015年06月10日 內容資訊: 英文 96 Pages
簡介

支架、人工心臟瓣膜等人工心臟設備,可用於維持心臟恰當功能。支架用於維持由於動脈閉塞而阻礙的血流,人工心臟瓣膜用於有心臟瓣膜的疾病、障礙的患者。預計全球人工心臟設備市場,2014∼2019年以年複合成長率8.41%擴大。

本報告提供全球人工心臟設備市場相關詳細分析、市場趨勢與2015∼2019年的成長預測、開發平台分析、各產品、各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

第4章 調查方法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 心臟瓣膜手術的成本分析

第8章 開發中產品

第9章 各產品全球人工心臟設備市場區隔

第10章 全球冠狀動脈支架市場

  • 市場規模與預測
  • 各類型市場區隔

第11章 全球心臟瓣膜市場

  • 市場規模與預測
  • 機械瓣膜
  • 組織瓣膜
  • 經導管心臟瓣膜

第12章 各地區市場區隔

  • 歐洲、中東、非洲
  • 南北美洲
  • 亞太地區

第13章 購買標準

第14章 市場成長的促進要素

第15章 促進要素與其影響

第16章 市場課題

第17章 促進要素與課題的影響

第18章 市場趨勢

第19章 趨勢與其影響

第20章 供應商環境

  • 競爭模式
  • 市場佔有率調查:2014年
  • 其他未來預計處於的供應商

第21章 主要供應商調查

  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Sorin Group株式會社
  • St. Jude Medical

第22章 本系列的其他報告

目錄
Product Code: IRTNTR6055

About cardiac prosthetic devices

Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being used by patient with heart valvular disease or dysfunctional heart valve.

Technavio's analysts forecast the global cardiac prosthetic market to grow at a CAGR of 8.41% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac prosthetic market for the period 2015-2019. The market can be segmented into two based on products: prosthetic heart valves and coronary stents.

Technavio's report, the Global Cardiac Prosthetic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global cardiac prosthetic market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Sorin Group
  • St. Jude Medical

Other Prominent Vendors

  • AorTech International
  • Abbott Vascular
  • Accellent
  • Admedes Schuessler
  • Alvimedica
  • Arbor Surgical
  • B. Braun Melsungen
  • Biosensors International
  • Biotronik
  • Boston Scientific
  • Bracco AMT
  • Colibri Heart Valve
  • Elixir Medical
  • eucatech
  • Eurocor
  • Hexacath
  • InspireMD
  • InSitu Technologies
  • iVascular
  • LEPU MEDICAL
  • Meril Life Sciences
  • Merit Medical
  • OrbusNeich
  • QT Vascular
  • Rontis
  • SCITECH
  • Shanghai MicroPort Scientific
  • STENTYS
  • Svelte Medical Systems
  • Symetis
  • Translumina

Market driver

  • Rise in birth prevalence of congenital heart disease worldwide
  • For a full, detailed list, view our report

Market challenge

  • Risk of complications and re-interventions
  • For a full, detailed list, view our report

Market trend

  • Increase in use of low-profile stents grafts for aneurysm repair
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Cost Analysis of Heart Valve Procedures

08. Pipeline Products

09. Global Cardiac Prosthetic Devices Market Segmentation by Product Type

10. Global Coronary Stents Market

  • 10.1. Market Size and Forecast
  • 10.2. Segmentation of Global Coronary Stents Market by Type

11. Global Heart Valves Market

  • 11.1. Market Size and Forecast
  • 11.2. Mechanical Heart Valves
    • 11.2.1. Market Size and Forecast
  • 11.3. Tissue Heart Valves
    • 11.3.1. Market Size and Forecast
  • 11.4. Transcatheter Heart Valves
    • 11.4.1. Market Size and Forecast

12. Geographical Segmentation

  • 12.1. Cardiac Prosthetic Devices Market in EMEA
    • 12.1.1. Market Size and Forecast
  • 12.2. Cardiac Prosthetic Devices Market in Americas
    • 12.2.1. Facility and Physician Billing Guide for Heart Valve Technologies in 2015
    • 12.2.2. Reimbursement Scenario for Cardiac Prosthetic Devices in US
    • 12.2.3. Market Size and Forecast
  • 12.3. Cardiac Prosthetic Devices Market in APAC
    • 12.3.1. Market Size and Forecast

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2014
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Boston Scientific
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Business Segmentation
    • 21.1.4. Business Segmentation by Revenue 2013
    • 21.1.5. Business Segmentation by Revenue 2012 and 2013
    • 21.1.6. Geographical Segmentation by Revenue 2013
    • 21.1.7. Business Strategy
    • 21.1.8. Recent Developments
    • 21.1.9. SWOT Analysis
  • 21.2. Edwards Lifesciences
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Business Segmentation by Revenue 2013
    • 21.2.4. Business Segmentation by Revenue 2012 and 2013
    • 21.2.5. Geographical Segmentation by Revenue 2013
    • 21.2.6. Business Strategy
    • 21.2.7. Recent Information
    • 21.2.8. SWOT Analysis
  • 21.3. Medtronic
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation
    • 21.3.4. Revenue by Business Segmentation
    • 21.3.5. Revenue Comparison by Business Segmentation 2012 and 2013
    • 21.3.6. Revenue by Geographical Segmentation
    • 21.3.7. Business Strategy
    • 21.3.8. Key Developments
    • 21.3.9. SWOT Analysis
  • 21.4. Sorin Group
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Business Segmentation by Revenue 2014
    • 21.4.4. Business Segmentation by Revenue 2013 and 2014
    • 21.4.5. Geographical Segmentation by Revenue 2014
    • 21.4.6. Business Strategy
    • 21.4.7. Recent Developments
    • 21.4.8. SWOT Analysis
  • 21.5. St. Jude Medical
    • 21.5.1. Key Facts
    • 21.5.2. Business Description
    • 21.5.3. Business Segmentation
    • 21.5.4. Business Strategy
    • 21.5.5. Revenue Segmentation by Business
    • 21.5.6. Revenue by Geographical Segmentation
    • 21.5.7. Key Information
    • 21.5.8. SWOT Analysis

22. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Cardiac Prosthetic Devices Market 2014-2019 ($ millions)
  • Exhibit 3: Types of Surgical Option
  • Exhibit 4: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type
  • Exhibit 5: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type 2014
  • Exhibit 6: Global Coronary Stents Market 2014-2019 ($ millions)
  • Exhibit 7: Segmentation of Coronary Stents by Type
  • Exhibit 8: Segmentation of Coronary Stents by Type 2014
  • Exhibit 9: Segmentation of Cardiac Prosthetic Heart Valves by Type
  • Exhibit 10: Global Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 11: Segmentation of Mechanical Heart Valves by Type
  • Exhibit 12: Biomaterials used in Different Valves
  • Exhibit 13: Characteristics of Mechanical Valves
  • Exhibit 14: Global Mechanical Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 15: Global Tissue Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 16: Global Transcatheter Heart Valves Market 2014-2019 ($ millions)
  • Exhibit 17: Segmentation of Cardiac Prosthetic Heart Devices 2014
  • Exhibit 18: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
  • Exhibit 19: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
  • Exhibit 20: Segmentation of Global Cardiac Prosthetic Devices Market 2014
  • Exhibit 21: Cardiac Prosthetic Devices Market in EMEA 2014-2019 ($ millions)
  • Exhibit 22: Cardiac Prosthetic Devices Market in Americas 2014-2019 ($ millions)
  • Exhibit 23: Cardiac Prosthetic Devices Market in APAC 2014-2019 ($ millions)
  • Exhibit 24: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019
  • Exhibit 25: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019 ($ millions)
  • Exhibit 26: Key Takeaways: Boston Scientific
  • Exhibit 27: Key Takeaways: Edwards Lifesciences
  • Exhibit 28: Key Takeaways: Medtronic
  • Exhibit 29: Key Takeaways: Sorin
  • Exhibit 30: Key Takeaways: St. Jude Medical
  • Exhibit 31: Boston Scientific: Business Segmentation
  • Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 35: Edwards Lifesciences: Business Segmentation by Revenue 2013
  • Exhibit 36: Edwards Lifesciences: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 37: Edwards Lifesciences: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Medtronic Inc.: Business Segmentation
  • Exhibit 39: Medtronic Inc.: Revenue by Business Segmentation 2013
  • Exhibit 40: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 41: Medtronic Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 42: Sorin Group: Business Segmentation by Revenue 2014
  • Exhibit 43: Sorin Group: Business Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 44: Sorin Group: Geographical Segmentation by Revenue 2014
  • Exhibit 45: St. Jude Medical: Business Segmentation
  • Exhibit 46: St. Jude Medical: Revenue by Business Segmentation 2013
  • Exhibit 47: St. Jude Medical: Revenue by Geographical Segmentation 2012
Back to Top